natgillin/translations-raw huggingface dataset:
The method according to claim 15, further comprising transferring said cognate pair or library of target-specific cognate pairs of variable region encoding sequences to a mammalian expression vector, wherein the mammalian expression vector optionally encodes one or more constant region domains selected from human immunoglobulin classes IgA1, IgA2, IgD, IgE, IgG1, IgG2, IgG3, IgG4, IgM, kappa light chain or lambda light chain. 
Postupak u skladu s patentnim zahtjevom 15, naznačen time što se dodatno sastoji u prebacivanju navedenog srodnog para ili biblioteke ciljno specifičnih srodnih parova sljedova koji kodiraju varijabilno područje u sisavački ekspresijski vektor, gdje navedeni sisavački ekspresijski vektor izborno kodira jednu ili više domena konstantnog područja, koje se bira između klasa ljudskih imunoglobulina IgA1, IgA2, IgD, IgE, IgG1, IgG2, IgG3, IgG4, IgM, lakog lanca kapa ili lakog lanca lambda.
A nucleic acid complex comprising a nucleic acid and a highly branched cyclic dextrin, wherein the highly branched cyclic dextrin is a glucan with a degree of polymerization of 50 to 5000 having an inner branched cyclic structure portion formed from a-1,4-glucoside bonds and at least one a-1,6-glucoside bond, and an outer branched structure portion bound to the inner branched cyclic structure portion. 
Kompleks nukleinske kiseline koji sadrži nukleinsku kiselinu i visoko razgranati ciklički dekstrin, naznačen time, da visoko razgranati ciklički dekstrin je glukan sa stupnjem polimerizacije od 50 do 5000 koji ima udio unutrašnje razgranate cikličke strukture formiran od a-1,4-glukozidnih veza i barem jedne a-1,6-glukozidne veze, te udio vanjske razgranate strukture vezan na udio unutarnje razgranate cikličke strukture.
The nucleic acid complex according to any one of claims 1 to 3, which is an aggregate obtained by mixing a nucleic acid with a highly branched cyclic dextrin in an aqueous solution. 
Kompleks nukleinske kiseline u skladu s bilo kojim zahtjevom 1 do 3, naznačen time, da je agregat dobiven miješanjem nukleinske kiseline s visoko razgranatim cikličkim dekstrinom u vodenoj otopini.
The nucleic acid delivery composition according to claim 6, wherein Component (A) in the nucleic acid delivery carrier is a diacylphosphatidylcholine in which the acyl moiety has 4 to 23 carbon atoms. 
Pripravak za oslobađanje nukleinske kiseline u skladu sa zahtjevom 6, naznačen time, da Sastojak (A) u nosaču za oslobađanje nukleinske kiseline je diacilfosfatidilholin u kojem acil udio ima 4 do 23 atoma ugljika.
The nucleic acid delivery composition according to claim 6, wherein the nucleic acid delivery carrier is a liposome preparation in which a liposome membrane is formed from Components (A) to (C). 
Pripravak za oslobađanje nukleinske kiseline u skladu sa zahtjevom 6, naznačen time, da nosač za oslobađanje nukleinske kiseline je liposomski pripravak u kojem je liposomska membrana formirana od Sastojaka (A) do (C).
A method according to claim 21 wherein the S-4-[4-(dimethylamino)-1-(4'-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile is reacted with a reactive acid derivative such as an acid chloride or acid anhydride, in particular methyl sulfonylchloride or p-toluene sulfonylchloride, in the presence of a base, such as triethylamine or pyridine. 
Postupak prema zahtjevu 18, naznačen time, što S-4-[4-(dimetilamino)-1-(4'-fluorofenil)-1-hidroksibutil]-3-(hidroksimetil)-benzonitril reagira sa derivatom reaktivne kiseline kao što je kiseli klorid ili kiseli anhidrid, u prisustvu baze.
The compound or composition for use according to claim 1, wherein the disease or disorder is bone cancer. 
Spoj ili farmaceutski sastav za uporabu prema zahtjevu 3, naznačen time, da bolest ili poremećaj je rak ezofagusa.
The compound or composition for use according to claim 1, wherein the disease or disorder is a renal tumor. 
Spoj ili farmaceutski sastav za uporabu prema zahtjevu 3, naznačen time, da bolest ili poremećaj je rak debelog crijeva.
A therapeutically effective amount of a salt according to any one of claims 1-5 for use in a method of treating a disease which responds to an inhibition of protein kinase activity. 
Uporaba terapeutski učinkovite količine soli prema zahtjevu 1, naznačena time, da je za proizvodnju lijeka za liječenje bolesti koja odgovara inhibiciji djelovanja proteinske kinaze.
Material as claimed in claim 1 or 2, wherein said two outer plies are bonded by gluing at correspondence at least of said first linear protuberances. 
Materijal prema zahtjevu 1 ili 2, naznačen time što su dva navedena vanjska sloja (V1, V2) vezana ljepljenjem barem na spoju navedenih prvih linearnih ispupčenja (5, 7).
Material as claimed in one or more of the previous claims, wherein the second protuberances of the outer plies have a density comprised between 1 and 25 protuberances/cm2 and preferably between 3 and 8 protuberances/cm2. 
Materijal prema jednom od, ili više prethodnih zahtjeva, naznačen time što druga ispupčenja (9, 11) vanjskih slojeva (V1, V2) imaju gustoću između 1 i 25 ispupčenja/cm2 i po mogućnosti između 3 i 8 ispupčenja/cm2.
A toothbrush (10) according to claim 1 characterized in that two or more of the spines (16,17,18) meet adjacent to the first and second ends (12,13) of the handle (11). 
Četkica za zube (10), u skladu s patentnim zahtjevom 1, naznačena time što se dvije ili više prečki (16, 17, 18) sreću uz prvi i drugi kraj (12, 13) drške (11).
A toothbrush (10) according to any one of the preceding claims characterized in that the elastomer material is a thermoplastic elastomer material (114) having a Shore A hardness in the range 5-30. 
Četkica za zube (10), u skladu s bilo kojim od prethodnih patentnih zahtjeva, naznačena time što elastomerni materijal je termoplastični elastomerni materijal (114) i ima tvrdoću Shore A u rasponu od 5-30.
Packaging group (10) according to claim 1, characterised in that said spokes (22) are regularly spaced from each other in accordance with one same angle. 
Grupa za pakiranje (10) u skladu s patentnim zahtjevom 1, naznačena time što su navedene žbice (22) razmaknute ravnomjerno jedna od druge, i to s jednakim kutom između njih.
Packaging machine (100) according to claim 7, characterised in that it comprises suction means of portions of said two plastic films (17, 17') separated by said packaged products (11). 
Stroj za pakiranje (100) u skladu s patentnim zahtjevom 7, naznačen time što stroj sadržava sredstvo za usisavanje dijelova navedene dvije folije od plastike (17, 17 ́), koji dijelovi se odvajaju kod zapakiranih navedenih proizvoda (11).
Packaging machine (100) according to claim 7, characterised in that said packaging group (10) is synchronised with said conveyor (103). 
Stroj za pakiranje (100) u skladu s patentnim zahtjevom 7, naznačen time što je navedena grupa za pakiranje (10) sinkronizirana s navedenom transportnom trakom (103).
Device as in claim 9, characterised in that the diverting ribs (34) favourably extend to the height of the horizontal diverting rib (31), and with their slanting diverting surface they come out onto the internal surface of the wall of the housing (1). 
Naprava u skladu s patentnim zahtjevom 9, naznačena time što se izbočine za skretanje (34) po mogućnosti pružaju do visine vodoravne izbočine za skretanje (31), a svojom nagnutom površinom za skretanje izlaze na unutarnju površinu stijenke kućišta (1).
Device as in any of claims 7-10, characterised in that the flat upper guiding surface (24a) of the chamber (18) runs into the lower curved guiding surface with a steeper guiding surface section. 
Naprava u skladu s bilo kojim od patentnih zahtjeva 7-10, naznačena time što ravna gornja površina za vođenje (24a) komore (18) prema donjoj zakrivljenoj površini za vođenje strmijim dijelom površine za vođenje.
A compound according to claim 11, or a pharmaceutically acceptable salt thereof, wherein R3 is methyl and the sterocentre produced has the (R)-configuration. 
Spoj u skladu s patentnim zahtjevom 11 ili njegova farmaceutski prihvatljiva sol, naznačen time, da R3 je metil, a nastali stereocentar ima (R)-konfiguraciju.
A process according to claim 1, wherein the said polysaccharide containing biomass is a lignocellulosic biomass derived from agricultural crops consisting of e.g. corn stover, bagasse, straw e.g. from rice, wheat, rye, oat, barley, rye, rape and sorghum, tubers e.g. beet, potato, cereals from e.g. rice, wheat, rye, oat, barley, rye, rape, sorghum, wood consisting of softwood e.g. Pinus sylvestris, Pinus radiata, hardwood e.g. Salix spp., Eucalyptus spp . or municipal solid waste, waste paper, fibre fraction from processing of biogas, manure and similar biomasses. 
Postupak prema patentnom zahtjevu 1, naznačen time što je navedena biomasa koja sadrži polisaharide lignocelulozna biomasa porijeklom od poljoprivrednih usjeva koji se sastoje od npr. kukuruzne stočne hrane, usitnjene pulpe šećerne trske koja ostaje poslije cijeđenja soka, slame npr. od riže, pšenice, raži, ovsa, ječma, uljane repice i kineske šećerne trske, drveta koje se sastoji od mekog drveta npr. Pinus sylvestris, Pinus radiata, tvrdog drveta npr. Salix spp., Eucalyptus spp. ili komunalnog čvrstog otpada, starog papira, frakcije vlakana iz obrade bio plina, gnojiva i slične biomase.
A process according to claim 1, wherein the said polysaccharide containing biomass is a mixture of starch, e.g. starch containing grains or refined starch, and lignocellulosic biomasses derived from agricultural crops consisting of e.g. corn stover, straw e.g. from rice, wheat, rye, oat, barley, rye, rape and sorghum, tubers e.g. beet, potato, cereals from e.g. rice, wheat, rye, oat, barley, rye, rape, sorghum, wood consisting of softwood e.g. Pinus sylvestris, Pinus radiata, hardwood e.g. Salix spp., Eucalyptus spp ., municipal solid waste, waste paper and similar biomasses. 
Postupak prema patentnom zahtjevu 1, naznačen time što je navedena biomasa koja sadrži polisaharide smjesa škroba, npr. zrna koja sadrže škrob ili rafiniranog škroba, i lignocelulozne biomase porijeklom od poljoprivrednih usjeva koji se sastoje od npr. kukuruzne stočne hrane, slame npr. od riže, pšenice, raži, ovsa, ječma, uljane repice i kineske šećerne trske, drveta koje se sastoji od mekog drveta npr. Pinus sylvestris, Pinus radiata, tvrdog drveta npr. Salix spp., Eucalyptus spp., komunalnog čvrstog otpada, starog papira i slične biomase.
A process according to any of claim 1, 2 or 4 wherein at least 20% (w/w) of the lignocellulosic biomass has a fibre size above 26 mm. 
Postupak prema bilo kojem od patentnih zahtjeva 1-3, naznačen time što najmanje 20% (tež./tež.) lignocelulozne biomase ima veličinu vlakana preko .
A process according to any of claims 1-10, wherein the time of treatment for the enzymatic hydrolysis is 0-72 hours. 
Postupak prema bilo kojem od patentnih zahtjeva 1-10, naznačen time što je vrijeme tretmana za enzimsku hidrolizu jednako 0-72 sata.
The bag-in-container according to any of the preceding claims, wherein mechanical adhesion is locally enhanced by a protrusion formed by both inner and outer layers. 
Posuda s vrećicom unutar nje prema bilo kojem od prethodnih patentnih zahtjeva, naznačena time da je mehaničko prianjanje lokalno pojačano izbočinom koju formiraju oba sloja, unutrašnji i vanjski.
The bag-in-container according to any of the preceding claims, wherein the inner (21) and outer (22) layers are different materials. 
Posuda s vrećicom unutar nje prema bilo kojem od prethodnih patentnih zahtjeva, naznačena time da su unutrašnji (21) i vanjski (22) slojevi od različitih materijala.
The bag-in-container according to any of claims 1 to 4, wherein the inner (21) and outer (22) layers are the same material. 
Posuda s vrećicom unutar nje prema bilo kojim patentnom zahtjevu 1 do 4, naznačena time da su unutrašnji (21) i vanjski (22) slojevi od istog materijala.
The bag-in-container according to any of the preceding claims, wherein the inner (21) and outer (22) layer are a material selected from PET, PEN, PTT, PA, PP, PE, HDPE, EVOH, PGAc, PLA, and copolymers or blends thereof. 
Posuda s vrećicom unutar nje prema bilo kojem od prethodnih patentnih zahtjeva, naznačena time da su unutrašnji (21) i vanjski (22) sloj od materijala izabranih od PET, PEN, PTT, PA, PP, PE, HDPE, EVOM, PGAc, PLA i kopolimera ili njihovih mješavina.
The bag-in-container according to any of the preceding claims, wherein the at least one vent (3) is in the shape of a wedge with the broad side at the level of the opening thereof and getting thinner as it penetrates deeper into the vessel, until the inner (21) and outer (22) layers meet to form an interface (14). 
Posuda s vrećicom unutar nje prema bilo kojem od prethodnih patentnih zahtjeva, naznačena time da je barem jedan otvor (3) u obliku klina sa širokom stranom u ravnini s otvorom istoga te koji se sužava kako dublje ulazi u posudu, dok se unutrašnji (21) i vanjski (22) slojevi ne sastanu tako da oblikuju međuprostor (14).
characterized in that, during the blow-moulding process, the bag (21) is anchored to the outer layer (22) at least one point remote from said single opening. 
naznačen time da je, za vrijeme postupka oblikovanja u kalupu puhanjem, vrećica (21) pričvršćena na vanjski sloj (22) barem jedno mjesto dalje od spomenutog pojedinog otvora.
• an inner layer (21) forming the bag and an outer layer (22) forming the container; 
• unutrašnji sloj (21) koji tvori vrećicu i vanjski sloj (22) koji tvori posudu;
The mould according to claim 14, wherein said means is suitable for creating mechanical adhesion between the inner and outer layers and includes a sump. 
Kalup prema patentnom zahtjevu 14, naznačen time da je spomenuto sredstvo pogodno za postizanje mehaničkog spajanja između unutrašnjih i vanjskih slojeva i obuhvaća udubinu.
The compound of claim 1 wherein R1 is selected from the group consisting of phenyl(C1-3)alkyl, pyridinyl(C1-3)alkyl, and furanyl(C1-3)alkyl; wherein phenyl, pyridinyl, and furanyl are optionally substituted with one to three R11 substituents independently selected from the group consisting of C1-3alkoxy; tetrazolyl, C3-6cycloalkylaminocarbonyl; hydroxy(C1-4)alkylaminocarbonyl; C6-10arylaminocarbonyl wherein C6-10aryl is optionally substituted with carboxy or C1-4alkoxycarbonyl; morpholin-4-ylcarbonyl; chloro; fluoro; trifluoromethoxy; C1-4alkoxycarbonyl; and carboxy; provided that no more than one R11 is C6-10arylaminocarbonyl. 
Spoj prema zahtjevu 1 naznačen time da R1 je izabran iz skupine koju čine fenil(C1-3)alkil, piridinil(C1-3)alkil, i furanil(C1-3)alkil; pri čemu fenil, piridinil, i furanil su proizvoljno supstituirani sa jednim do tri R11 supstituenta nezavisno izabrana iz skupine koju čine C1-3alkoksi; tetrazolil, C3-6cikloalkilaminokarbonil; hidroksi(C1-4)alkilaminokarbonil; C6-10arilaminokarbonil pri čemu C6-10aril je proizvoljno supstituiran sa karboksi ili C1-4alkoksikarbonilom; morfolin-4-ilkarbonil; kloro; fluoro; trifluorometoksi; C1-4alkoksikarbonil; i karboksi; uz uvjet da ne više od jedan R11 je C6-10arilaminokarbonil.
The compound of claim 1 wherein R1 is phenylmethyl, pyridinylmethyl, or furanylmethyl; wherein phenyl, pyridinyl, and furanyl are optionally substituted with one to three R11 substituents independently selected from the group consisting of methoxy; tetrazolyl; cyclopropylaminocarbonyl; (2-hydroxyeth-1-yl)aminocarbonyl; methoxycarbonyl; phenylaminocarbonyl wherein phenyl is optionally substituted with carboxy; morpholin-4-ylcarbonyl; and carboxy. 
Spoj prema zahtjevu 1 naznačen time da R1 je fenilmetil, piridinilmetil, ili furanilmetil; pri čemu fenil, piridinil, i furanil su proizvoljno supstituirani sa jednim do tri R11 supstituenta nezavisno izabrana iz skupine koju čine metoksi; tetrazolil; ciklopropilaminokarbonil; (2-hidroksiet-1-il)aminokarbonil; metoksikarbonil; fenilaminokarbonil pri čemu fenil je proizvoljno supstituiran sa karboksi; morfolin-4-ilkarbonil; i karboksi.
The compound of claim 1 wherein R2 is a substituent selected from the group consisting of hydrogen and C1-4alkyl. 
Spoj prema zahtjevu 1 naznačen time da R2 je supstituent izabran iz skupine koju čine vodik i C1-4alkil.
The compound of claim 1 wherein R3 is a substituent selected from the group consisting of methyl and phenyl; wherein phenyl is optionally substituted with one to two substituents independently selected from the group consisting of chloro and carboxy. 
Spoj prema zahtjevu 1 naznačen time da R3 je supstituent izabran iz skupine koju čine metil i fenil; pri čemu fenil je proizvoljno supstituiran sa jednim do dva supstituenta nezavisno izabrana iz skupine koju čine kloro i karboksi.
The compound of claim 1 wherein Ra and Rb are independently hydrogen or methyl. 
Spoj prema zahtjevu 1 naznačen time da Ra i Rb su nezavisno vodik ili metil.
Ra and Rb are independently hydrogen or C1-3alkyl; or, when Ra and Rb are each other than hydrogen, Ra and Rb are optionally taken together with the nitrogen atom to which they are both attached to form a five to seven membered monocyclic ring; and pharmaceutically acceptable enantiomers, diastereomers, racemates, and salts thereof. 
Ra i Rb su nezavisno vodik ili C1-3alkil; ili, kada Ra i Rb svaki nisu vodik, Ra i Rb su proizvoljno uzeti zajedno sa dušikom na koji su oba spojeni da oblikuju pet do sedam člani monociklički prsten; i njihovi farmaceutski prihvatljivi enantiomeri, diastereomeri, racemati i soli.
A compound of Formula (Ia) wherein: 
Spoj formule (Ia) naznačen time da:
A compound according to claim 32 wherein R1 is phenylmethyl, pyridinylmethyl, or furanylmethyl; wherein phenyl, pyridinyl, and furanyl are optionally substituted with one to three R11 substituents independently selected from is the group consisting of methoxy, tetrazolyl, cyclopropylaminocarbonyl, (2-hydroxyeth-1-yl)aminocarbonyl, phenylaminocarbonyl wherein phenyl is optionally substituted with carboxy, morpholin-4-ylcarbonyl, methoxycarbonyl, and carboxy; provided that no more than one R11 is phenylaminocarbonyl. 
Spoj prema zahtjevu 32 naznačen time da R1 je fenilmetil, piridinilmetil ili furanilmetil; pri čemu fenil, piridinil i furanil su proizvoljno supstituirani sa jednim do tri R11 supstituenta nezavisno izabrana iz skupine koju čine metoksi, tetrazolil, ciklopropilaminokarbonil, (2-hidroksiet-1-il)aminokarbonil, fenilaminokarbonil pri čemu fenil je proizvoljno supstituiran sa karboksi, morfolin-4-ilkarbonil, metoksikarbonil i karboksi; uz uvjet da ne više od jedan R11 je fenilaminokarbonil.
A process for liquefaction and saccharification of polysaccharide containing biomasses comprising lignocellulosic biomass, characterized in subjecting said biomass to combined enzymatic hydrolysis using at least one cellulase and mixing by a free fall mixer such as a drum mixer or a tumble mixer providing mechanical processing and/or degradation of the biomass so that, in the process, the biomass is liquefied and saccharified to a liquid suitable for further processing such as fermentation, wherein the biomass has a dry matter content of between 20% and 40% at the start of the mixing/hydrolysis. 
Postupak za topljenje i saharifikaciju biomase koja sadrži polisaharide i koja sadrži lignoceluloznu biomasu, naznačen time što se navedena biomasa podvrgava kombiniranoj enzimskoj hidrolizi primjenom najmanje jedne celulaze i miješanjem miješalicom sa slobodnim padom kao što je miješalica u obliku bubnja ili tambler miješalica osiguravajući mehaničku obradu i/ili razgradnju biomase tako da se, u postupku, biomasa topi i saharificira do tekućine pogodne za daljnju obradu kao što je fermentacija, pri čemu biomasa ima sadržaj suhe materije od između 20% i 40% na početku miješanja/hidrolize.
from rice, wheat, rye, oat, barley, rape and sorghum, wood consisting of softwood e.g. 
od riže, pšenice, raži, ovsa, ječma, uljane repice i kineske šećerne trske, drveta koje se sastoji od mekog drveta npr.
or municipal solid waste, waste paper, fibre fraction from processing of biogas, manure and similar biomasses. 
ili komunalnog čvrstog otpada, starog papira, frakcije vlakana iz obrade bio plina, gnojiva i slične biomase.
starch containing grains or refined starch, and lignocellulosic biomasses derived from agricultural crops consisting of e.g. 
zrna koja sadrže škrob ili rafiniranog škroba, i lignocelulozne biomase porijeklom od poljoprivrednih usjeva koji se sastoje od npr.
Salix spp., Eucalyptus spp., municipal solid waste, waste paper and similar biomasses. 
Salix spp., Eucalyptus spp., komunalnog čvrstog otpada, starog papira i slične biomase.
A process according to any of claims 1-3, wherein the liquid resulting from the process is suitable for further processing such as fermentation. 
Postupak prema bilo kojem od patentnih zahtjeva 1-3, naznačen time što je tekućina koja nastaje u postupku pogodna za daljnju obradu kao što je fermentacija.
A process according to any of claims 1-3 wherein at least 20% (w/w) of the lignocellulosic biomass has a fibre size above 26 mm. 
Postupak prema bilo kojem od patentnih zahtjeva 1-3, naznačen time što najmanje 20% (tež./tež.) lignocelulozne biomase ima veličinu vlakana preko .
A process according to claim 11, wherein the time of treatment is 3-24 hours. 
Postupak prema patentnom zahtjevu 11, naznačen time što je vrijeme tretmana jednako 3-24 sata.
A process according to claim 1 wherein mixing is provided by a mixer with a horizontally placed stirrer shaft lifting the biomass. 
Postupak prema patentnom zahtjevu 1, naznačen time što je miješanje osigurano pomoću miješalice sa horizontalno postavljenom miješajućom osovinom koja podiže biomasu.
A method of treatment of inflammatory diseases, disorders and conditions characterized by or associated with an undesirable inflammatory immune response, and all diseases and conditions induced by or associated with an excessive secretion of TNF-a and IL-1 which comprises administering to a subject a therapeutically effective amount of a compound according to claim 1 or 2 or 20. 
Upotreba spoja, ili njegove farmaceutski prihvatljive soli ili solvata, u skladu s bilo kojim od patentnih zahtjeva 1 do 3 u proizvodnji medikamenta za liječenje upalnih bolesti, poremećaja i stanja, naznačena time što je ili je povezana s nepoželjnim upalnim imunosnim odgovorom, te svim bolestima i stanjima uzrokovanim ili povezanim s prekomjernim izlučivanjem TNF-a i IL-1.
The method according to claim 33, wherein inflammatory conditions and immune disorders are selected from the group consisting of asthma, adult respiratory distress syndrome, chronic obstructive pulmonary disease, inflammatory bowel conditions, Crohn's disease, bronchitis, and cystic fibrosis. 
Upotreba u skladu s patentnim zahtjevom 11, naznačena time što se upalna stanja i imunosne poremećaje bira iz skupine koju čine astma, sindrom dišnog distresa kod odraslih, kronična opstruktivna plućna bolest, upalna stanja crijeva, Crohnova bolest, bronhitis i cistična fibroza.
A method according to claim 33, wherein said inflammatory conditions and immune disorders are selected from the group consisting of asthma, adult respiratory distress syndrome, bronchitis, cystic fibrosis, rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis, uveitis, conjunctivitis, inflammatory bowel conditions, Crohn's disease, ulcerative colitis, distal proctitis, psoriasis, eczema, dermatitis, coronary infarct damage, chronic inflammation, endotoxin shock, and smooth muscle proliferation disorders. 
Upotreba u skladu s patentnim zahtjevom 11, naznačena time što se navedena upalna stanja i imunosne poremećaje bira iz skupine koju čine astma, sindrom dišnog distresa kod odraslih, bronhitis, cistična fibroza, reumatoidni artritis, reumatoidni spondilitis, osteoartritis, gihtični artritis, uveitis, konjunktivitis, upalna stanja crijeva, Crohnova bolest, ulcerozni kolitis, distalni proktitis, psorijaza, ekzem, dermatitis, oštećenje nakon koronarnog infarkta, kronična upala, endotoksinski šok, te poremećaji proliferacije glatkih mišića.